Aviso Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4,308
Closed -$263K 145
2025
Q1
$263K Sell
4,308
-2,444
-36% -$142K 0.14% 121
2024
Q4
$382K Sell
6,752
-141
-2% -$7.88K 0.19% 102
2024
Q3
$357K Sell
6,893
-4,248
-38% -$199K 0.19% 106
2024
Q2
$463K Sell
11,141
-5,933
-35% -$265K 0.27% 83
2024
Q1
$926K Buy
17,074
+12,551
+277% +$639K 0.58% 45
2023
Q4
$232K Buy
+4,523
New +$237K 0.17% 128

Other funds holding BMY

Aviso Wealth Management's BMY Position: Q2 2025 in Review

Aviso Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 4,308 shares — an estimated $263K sold.

Aviso Wealth Management first reported a position in BMY in Q4 2023 and held it in 6 quarters. The position peaked at $926K in Q1 2024. 2,293 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

  • Aviso Wealth Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
  • Aviso Wealth Management sold 4,308 Bristol-Myers Squibb shares in Q2 2025, an estimated $263K.
  • Aviso Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and held it in 6 quarters.
  • Aviso Wealth Management's Bristol-Myers Squibb position peaked at $926K in Q1 2024.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Aviso Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.